Hasil Pencarian - Inbal Barbiro

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    29 Immune modulation and baseline biomarker correlation with clinical benefit following treatment with COM701+nivolumab+/-BMS-986207 in patients with platinum resistant ovarian cancer

    29 Immune modulation and baseline biomarker correlation with clinical benefit following treatment with COM701+nivolumab+/-BMS-986207 in patients with platinum resistant ovarian can... oleh Yu Liang, Gady Cojocaru, Inbal Barbiro, Zurit Levine, Eran Ophir, Zoya Alteber, Pierre Ferre, Assaf Wool, Roy Granit, Adi Shuchami

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    478 COM701 in combination with BMS-986207 (anti-TIGIT antibody) and nivolumab – preliminary results of safety, tolerability and pharmacokinetics in patients with advanced solid tumors (NCT04570839)

    478 COM701 in combination with BMS-986207 (anti-TIGIT antibody) and nivolumab – preliminary results of safety, tolerability and pharmacokinetics in patients with advanced solid tum... oleh Inbal Barbiro, Amita Patnaik, Manish Sharma, Drew Rasco, Ryan Sullivan, Ecaterina Dumbrava, Pierre Ferre, Gini Fleming, Kyriakos Papadopoulos, Daniel Vaena, Adam ElNaggar, Adeboye Adewoye, Robina Smith, Emerson Lim

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer

    640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer oleh Gady Cojocaru, Inbal Barbiro, Manish Patel, Manish Sharma, Dale Shepard, Drew Rasco, Bartosz Chmielowski, Kyriakos P Papadopoulos, Eran Ophir, Ecaterina Dumbrava, Erika Hamilton, Pierre Ferre, Daniel Vaena, Judy S Wang, Adeboye H Adewoye

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    669 Durable responses with triple blockade of the DNAM-1 axis with COM701 + BMS-986207 + nivolumab in patients with platinum resistant ovarian cancer

    669 Durable responses with triple blockade of the DNAM-1 axis with COM701 + BMS-986207 + nivolumab in patients with platinum resistant ovarian cancer oleh Gady Cojocaru, Inbal Barbiro, Amita Patnaik, Manish Sharma, Drew Rasco, Benjamin Izar, Kyriakos P Papadopoulos, Eran Ophir, Ryan Sullivan, Pierre Ferre, Stéphanie Gaillard, Daniel Vaena, Oladapo Yeku, John Moroney, Adeboye H Adewoye

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: